Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
Clinical trial NCT06743438 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06743438
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-10
- Primary completion
- 2024-06-30
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.